Report Detail
Global Opioids Drug Market Growth 2019-2024
- RnM2996325 |
- 21 February, 2019 |
- Global |
- 165 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
According to this study, over the next five years the Opioids Drug market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Opioids Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Opioids Drug market by product type, application, key manufacturers and key regions and countries.
This study considers the Opioids Drug value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Pain Relief
Anesthesia
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Opioids Drug consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Opioids Drug market by identifying its various subsegments.
Focuses on the key global Opioids Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Opioids Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Opioids Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Opioids Drug Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Opioids Drug Consumption 2014-2024
- 2.1.2 Opioids Drug Consumption CAGR by Region
- 2.2 Opioids Drug Segment by Type
- 2.2.1 Oxycodone
- 2.2.2 Hydromorphone
- 2.2.3 Codeine
- 2.2.4 Fentanyl
- 2.2.5 Other
- 2.3 Opioids Drug Consumption by Type
- 2.3.1 Global Opioids Drug Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Opioids Drug Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Opioids Drug Sale Price by Type (2014-2019)
- 2.4 Opioids Drug Segment by Application
- 2.4.1 Pain Relief
- 2.4.2 Anesthesia
- 2.4.3 Other
- 2.5 Opioids Drug Consumption by Application
- 2.5.1 Global Opioids Drug Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Opioids Drug Value and Market Share by Application (2014-2019)
- 2.5.3 Global Opioids Drug Sale Price by Application (2014-2019)
3 Global Opioids Drug by Players
- 3.1 Global Opioids Drug Sales Market Share by Players
- 3.1.1 Global Opioids Drug Sales by Players (2017-2019)
- 3.1.2 Global Opioids Drug Sales Market Share by Players (2017-2019)
- 3.2 Global Opioids Drug Revenue Market Share by Players
- 3.2.1 Global Opioids Drug Revenue by Players (2017-2019)
- 3.2.2 Global Opioids Drug Revenue Market Share by Players (2017-2019)
- 3.3 Global Opioids Drug Sale Price by Players
- 3.4 Global Opioids Drug Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Opioids Drug Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Opioids Drug Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Opioids Drug by Regions
- 4.1 Opioids Drug by Regions
- 4.1.1 Global Opioids Drug Consumption by Regions
- 4.1.2 Global Opioids Drug Value by Regions
- 4.2 Americas Opioids Drug Consumption Growth
- 4.3 APAC Opioids Drug Consumption Growth
- 4.4 Europe Opioids Drug Consumption Growth
- 4.5 Middle East & Africa Opioids Drug Consumption Growth
5 Americas
- 5.1 Americas Opioids Drug Consumption by Countries
- 5.1.1 Americas Opioids Drug Consumption by Countries (2014-2019)
- 5.1.2 Americas Opioids Drug Value by Countries (2014-2019)
- 5.2 Americas Opioids Drug Consumption by Type
- 5.3 Americas Opioids Drug Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Opioids Drug Consumption by Countries
- 6.1.1 APAC Opioids Drug Consumption by Countries (2014-2019)
- 6.1.2 APAC Opioids Drug Value by Countries (2014-2019)
- 6.2 APAC Opioids Drug Consumption by Type
- 6.3 APAC Opioids Drug Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Opioids Drug by Countries
- 7.1.1 Europe Opioids Drug Consumption by Countries (2014-2019)
- 7.1.2 Europe Opioids Drug Value by Countries (2014-2019)
- 7.2 Europe Opioids Drug Consumption by Type
- 7.3 Europe Opioids Drug Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Opioids Drug by Countries
- 8.1.1 Middle East & Africa Opioids Drug Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Opioids Drug Value by Countries (2014-2019)
- 8.2 Middle East & Africa Opioids Drug Consumption by Type
- 8.3 Middle East & Africa Opioids Drug Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Opioids Drug Distributors
- 10.3 Opioids Drug Customer
11 Global Opioids Drug Market Forecast
- 11.1 Global Opioids Drug Consumption Forecast (2019-2024)
- 11.2 Global Opioids Drug Forecast by Regions
- 11.2.1 Global Opioids Drug Forecast by Regions (2019-2024)
- 11.2.2 Global Opioids Drug Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Opioids Drug Forecast by Type
- 11.8 Global Opioids Drug Forecast by Application
12 Key Players Analysis
- 12.1 Purdue Pharma
- 12.1.1 Company Details
- 12.1.2 Opioids Drug Product Offered
- 12.1.3 Purdue Pharma Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Purdue Pharma News
- 12.2 J&J
- 12.2.1 Company Details
- 12.2.2 Opioids Drug Product Offered
- 12.2.3 J&J Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 J&J News
- 12.3 Teva
- 12.3.1 Company Details
- 12.3.2 Opioids Drug Product Offered
- 12.3.3 Teva Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Teva News
- 12.4 Mylan
- 12.4.1 Company Details
- 12.4.2 Opioids Drug Product Offered
- 12.4.3 Mylan Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Mylan News
- 12.5 Depomed
- 12.5.1 Company Details
- 12.5.2 Opioids Drug Product Offered
- 12.5.3 Depomed Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Depomed News
- 12.6 INSYS
- 12.6.1 Company Details
- 12.6.2 Opioids Drug Product Offered
- 12.6.3 INSYS Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 INSYS News
- 12.7 Endo
- 12.7.1 Company Details
- 12.7.2 Opioids Drug Product Offered
- 12.7.3 Endo Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Endo News
- 12.8 Pfizer
- 12.8.1 Company Details
- 12.8.2 Opioids Drug Product Offered
- 12.8.3 Pfizer Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Pfizer News
- 12.9 Hikma
- 12.9.1 Company Details
- 12.9.2 Opioids Drug Product Offered
- 12.9.3 Hikma Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Hikma News
- 12.10 Mallinckrodt
- 12.10.1 Company Details
- 12.10.2 Opioids Drug Product Offered
- 12.10.3 Mallinckrodt Opioids Drug Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Mallinckrodt News
- 12.11 Pernix
- 12.12 Egalet
- 12.13 Vistapharm
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Opioids Drug . Industry analysis & Market Report on Opioids Drug is a syndicated market report, published as Global Opioids Drug Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Opioids Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
